Rare diseases
Investigational molecules
Locations
Back to Belgium1 305 clinical trials in Charleroi, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
BelgiumStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
BelgiumStudy on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis
BelgiumStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
BelgiumStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
BelgiumStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
BelgiumStudy on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides
BelgiumStudy of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments
BelgiumStudy on Tralokinumab and Topical Corticosteroids for Children and Infants with Moderate-to-Severe Atopic Dermatitis
BelgiumEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
BelgiumStudy Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in breast cancer, lung cancer, and head and neck cancers. Studies evaluate novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Multiple trials investigating personalized medicine approaches and biomarker-driven treatments.
Research examining treatments for coronary artery disease and post-cardiac arrest care. Trials focus on innovative stent technologies and antiplatelet therapy optimization.
Emphasis on improving patient outcomes through targeted interventional approaches.
Clinical investigations targeting inflammatory skin conditions and immune-mediated disorders. Studies evaluate novel treatments for psoriasis and other dermatological conditions.
Focus on developing targeted therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
